Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal cancer and associated conditions, including inflammatory bowel disease (IBD), diverticulitis, and Crohn’s disease, along with heightened awareness and the expansion of screening programs. This growing demand is further reinforced by continuous product innovation from leading market players, resulting in the launch of advanced and minimally invasive surgical devices.
New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal cancer and associated conditions, including inflammatory bowel disease (IBD), diverticulitis, and Crohn’s disease, along with heightened awareness and the expansion of screening programs. This growing demand is further reinforced by continuous product innovation from leading market players, resulting in the launch of advanced and minimally invasive surgical devices.
DelveInsight’s Colorectal Surgical Devices Market Insights report provides the current and forecast market analysis, individual leading colorectal surgical devices companies’ market shares, challenges, colorectal surgical devices market drivers, barriers, trends, and key market colorectal surgical devices companies in the market.
Colorectal Surgical Devices Market Summary
- The global colorectal surgical devices market is expected to grow at a CAGR of ~8% during the forecast period from 2025 to 2032.
- The leading companies working in the colorectal surgical devices market include Medtronic, Johnson & Johnson Services, Inc., Stryker, Olympus Corporation, CONMED Corporation., B. Braun SE, Boston Scientific Corporation, Cook, Cooper Surgical Inc., Teleflex Incorporated, Intuitive Surgical Operations, Inc., Applied Medical Resources Corporation, Richard Wolf GmbH, Karl Storz, Fujifilm, Volkmann Medizintechnik Gmbh, Ezisurg Medical Co., Ltd., Sontec Instruments, Inc., Mahr Surgical, Thompson Surgical, and others.
- Among all the regions, North America is anticipated to register the fastest growth in the colorectal surgical devices market during the forecasted period.
- In the product type segment of the colorectal surgical devices market, the stapler devices category captured a significant revenue share in 2024.
To read more about the latest highlights related to the colorectal surgical devices market, get a snapshot of the key highlights entailed in the Global Colorectal Surgical Devices Market Forecast Report
Key Factors Contributing to the Rise in Growth of the Colorectal Surgical Devices Market
Rising Incidence of Colorectal Cancer and Related Diseases
The increasing prevalence of colorectal cancer, polyps, and inflammatory bowel diseases worldwide is a primary driver for the market. Early detection and surgical intervention are critical in improving patient outcomes, which has significantly increased the demand for advanced colorectal surgical devices.
Advancements in Minimally Invasive Surgical Techniques
Technological innovations, such as laparoscopic and robotic-assisted surgeries, have revolutionized colorectal procedures. These minimally invasive techniques offer reduced recovery times, lower complication rates, and improved precision, leading to higher adoption of sophisticated surgical instruments and devices.
Growing Geriatric Population
The aging population is more susceptible to colorectal diseases. With increasing life expectancy, there is a higher incidence of conditions requiring surgical intervention, which in turn boosts the demand for colorectal surgical devices specifically designed for elderly patients.
Expansion of Screening and Early Diagnosis Programs
Government and private initiatives promoting colorectal cancer screening and early diagnosis have increased the identification of cases that require surgical management. The rise in colonoscopy procedures and other diagnostic tools has further fueled the need for corresponding surgical devices.
Continuous R&D and Product Innovations
Ongoing research and development in surgical tools, including energy-based devices, staplers, and specialized instruments for complex colorectal procedures, are driving the market. Innovations aimed at improving efficiency, precision, and safety are encouraging hospitals and surgical centers to adopt the latest devices.
Increasing Healthcare Expenditure and Infrastructure
Higher investments in healthcare infrastructure, particularly in developed regions, have improved access to advanced surgical treatments. Well-equipped hospitals and surgical centers are increasingly adopting high-quality colorectal surgical devices to enhance patient care.
Get a sneak peek at the colorectal surgical devices market dynamics @ Colorectal Surgical Devices Market Trends
Regional Colorectal Surgical Devices Market Insights
North America is expected to hold the largest share of the colorectal surgical device market. This market leadership is driven by the high prevalence of colorectal cancer, well-developed healthcare infrastructure, robust screening programs, and early detection rates. The region also benefits from the presence of major industry players, substantial healthcare expenditures, and ongoing R&D investments, which enhance its global competitiveness.
Furthermore, ongoing product development initiatives are propelling market growth in the region. For example, in May 2023, Olympus received FDA clearance for its new EVIS X1™ endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 for the upper digestive tract and the CF-HQ1100DL/I for the lower digestive tract. This system features advanced imaging technologies that assist physicians in diagnosing, treating, and monitoring gastrointestinal conditions, including acid reflux, ulcers, Crohn’s disease, and colorectal cancer.
In April 2025, Intuitive announced FDA clearance for its fully wristed SP SureForm 45 stapler in the U.S., designed for use with the da Vinci SP single-port robotic surgical system in thoracic, colorectal, and urologic procedures. The stapler, the first created specifically for single-port robotic surgery, integrates SmartFire technology to monitor tissue compression before and during firing continuously, ensuring staple line integrity while minimizing tissue damage.
Overall, North America is projected to remain the largest market for colorectal surgical devices throughout the forecast period from 2025 to 2032.
To know more about why North America is leading the market growth in the colorectal surgical devices market, get a snapshot of the Colorectal Surgical Devices Market Outlook
Recent Developmental Activities in the Colorectal Surgical Devices Market
- In April 2025, Intuitive announced that the U.S. FDA cleared its fully wristed SP SureForm 45 stapler for use with the da Vinci SP single-port robotic surgical system in thoracic, colorectal, and urologic procedures.
- In September 2024, Odin Medical Ltd., a subsidiary of Olympus Corporation, received FDA 510(k) clearance for CADDIE, the first cloud-based AI computer-aided detection (CADe) device for colonoscopy. Designed to assist gastroenterologists in the real-time detection of suspected colorectal polyps by analyzing video and providing visual alerts, CADDIE is the first cloud-based AI CADe device for colonoscopy.
- In August 2024, Olympus Corporation launched two new jaw designs in its POWERSEAL™ Sealer/Divider line: the Straight Jaw, Double-action (SJDA) and the Curved Jaw, Single-action (CJSA). They are approved for use in the U.S., Canada, the EU, and other regions. These devices provide efficient sealing, dissection, and grasping in both laparoscopic and open surgeries. They are indicated for multiple procedures, including colorectal, general, gynecological, and bariatric surgeries, while requiring less force to close the jaws.
- In August 2024, Colospan received FDA Breakthrough Device Designation for its CG-100 intraluminal bypass device. The device is intended for colorectal cancer patients undergoing anastomosis with a protective stoma.
Colorectal Surgical Devices Overview
Colorectal surgical devices are specialized instruments designed to support a wide range of procedures for the diagnosis, treatment, and management of conditions affecting the colon, rectum, and anus. These devices play a critical role in minimally invasive and open surgeries, including resections, anastomosis, and colostomy creation. Key products include stapling devices, energy-based surgical instruments, hand-held tools, and laparoscopic systems that enhance precision, reduce operative time, and minimize postoperative complications. With the growing prevalence of colorectal cancer, inflammatory bowel disease, and diverticulitis, the demand for advanced devices that improve surgical outcomes and patient recovery has risen significantly.
| Colorectal Surgical Devices Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Colorectal Surgical Devices Market CAGR | ~8% |
| Key Colorectal Surgical Devices Companies | Medtronic, Johnson & Johnson Services, Inc., Stryker, Olympus Corporation, CONMED Corporation., B. Braun SE, Boston Scientific Corporation, Cook, Cooper Surgical Inc., Teleflex Incorporated, Intuitive Surgical Operations, Inc., Applied Medical Resources Corporation, Richard Wolf GmbH, Karl Storz, Fujifilm, Volkmann Medizintechnik Gmbh, Ezisurg Medical Co., Ltd., Sontec Instruments, Inc., Mahr Surgical, Thompson Surgical, and others |
Colorectal Surgical Devices Market Assessment
-
Colorectal Surgical Devices Market Segmentation
- Colorectal Surgical Devices Market Segmentation By Product Type: Endoscopes, Stapler Devices, Cutters, Sealing Devices, and Accessories
- Colorectal Surgical Devices Market Segmentation By Surgery Type: Open Surgery and Minimally Invasive
- Colorectal Surgical Devices Market Segmentation By End-User: Hospitals & Clinics, Surgical Centers, and Others
- Colorectal Surgical Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the colorectal surgical devices market are set to emerge as the trendsetter explore @ Colorectal Surgical Devices Market Analysis
Table of Contents
| 1 | Colorectal Surgical Devices Market Report Introduction |
| 2 | Colorectal Surgical Devices Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Colorectal Surgical Devices Market Key Factors Analysis |
| 6 | Colorectal Surgical Devices Market Porter’s Five Forces Analysis |
| 7 | Colorectal Surgical Devices Market Layout |
| 8 | Colorectal Surgical Devices Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the colorectal surgical devices market by 2032? Click to get a snapshot of the Colorectal Surgical Devices Market Assessment
Related Reports
Colorectal Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key colorectal cancer companies, including Mirati Therapeutics, Exelixis, Enterome, Arcus Biosciences, Lyell Immunopharma, AstraZeneca, Novartis Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical, Bristol-Myers Squibb, NGM Biopharmaceuticals, Takeda, PureTech, Pfizer, Kezar Life Sciences, Salubris Biotherapeutics, among others. The total colorectal cancer market size in 2023 was approximately USD 13,000 million in the 7MM, which is expected to grow at a CAGR of ~5% during the forecast period (2024-2034).
Colorectal Cancer Clinical Trial Analysis
Colorectal Cancer Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key colorectal cancer companies, including Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc., Neogap Therapeutics AB, Criterium, Inc., Daiichi Sankyo, Inc., Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, among others.
Inflammatory Bowel Disease Market
Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key IBD companies including Takeda Pharmaceutical, Janssen Pharmaceuticals, Hoffmann-La Roche, Genentech, AbbVie, Boehringer Ingelheim, Gilead Sciences, Arena Pharmaceuticals, Eli Lilly, AstraZeneca, among others.
Crohn's Disease Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Crohn's disease companies including RedHill Biopharma, Merck, Teva Pharmaceutical, Pfizer, Agomab Therapeutics, Sanofi, Medibiofarma, Eli Lilly, Morphic Therapeutics, NImmune, Avobis Bio, Abivax, Roche, Mesoblast, Takeda, AstraZeneca, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, UCB, Biogen, Arena Pharma, among others.
Ulcerative Colitis Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ulcerative colitis companies including Arena Pharmaceuticals, Pfizer, Abivax, Reistone Biopharma, InDex Pharmaceuticals, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck, Mesoblast, among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
